These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31202566)

  • 1. Are patients with mild to moderate renal impairment on metformin or other oral anti-hyperglycaemic agents at increased risk of contrast-induced nephropathy and metabolic acidosis after radiocontrast exposure?
    Jung J; Cho YY; Jung JH; Kim KY; Kim HS; Baek JH; Hahm JR; Cho HS; Kim SK
    Clin Radiol; 2019 Aug; 74(8):651.e1-651.e6. PubMed ID: 31202566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between use of metformin and change in serum CO2 level after administration of contrast medium.
    Kim SK; Jung J; Jung JH; Kim KY; Baek JH; Hahm JR
    Clin Radiol; 2016 Jun; 71(6):532-6. PubMed ID: 27063815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin-associated lactic acidosis following contrast media-induced nephrotoxicity.
    Jain V; Sharma D; Prabhakar H; Dash HH
    Eur J Anaesthesiol; 2008 Feb; 25(2):166-7. PubMed ID: 18251038
    [No Abstract]   [Full Text] [Related]  

  • 4. Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease.
    Sipahi S; Solak Y; Acikgoz SB; Genc AB; Yildirim M; Yilmaz U; Nalbant A; Tamer A
    Int Urol Nephrol; 2016 Aug; 48(8):1305-1312. PubMed ID: 27102431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of lactic acidosis due to metformin intoxication in contrast media nephropathy].
    Landewé-Cleuren S; van Zwam WH; de Bruin TW; de Haan M
    Ned Tijdschr Geneeskd; 2000 Sep; 144(40):1903-5. PubMed ID: 11045136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why hold the metformin?
    King JE
    Nursing; 2004 Jul; 34(7):20. PubMed ID: 15241265
    [No Abstract]   [Full Text] [Related]  

  • 7. Metformin and contrast media: where is the conflict?
    Rasuli P; Hammond DI
    Can Assoc Radiol J; 1998 Jun; 49(3):161-6. PubMed ID: 9640281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alprostadil protects type 2 diabetes mellitus patients treated with metformin from contrast-induced nephropathy.
    Wang J; Ai X; Li L; Gao Y; Sun N; Li C; Sun W
    Int Urol Nephrol; 2017 Nov; 49(11):2019-2026. PubMed ID: 28656510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse event notifications implicating metformin with lactic acidosis in Australia.
    Huang W; Castelino RL; Peterson GM
    J Diabetes Complications; 2015; 29(8):1261-5. PubMed ID: 26104729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nephrotoxicity after the use of intravenous X-ray contrast media in a type 2 diabetic being treated with metformin].
    Bjarnason NH; Elung-Jensen T
    Ugeskr Laeger; 2006 May; 168(18):1772-3. PubMed ID: 16729932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study.
    Eppenga WL; Lalmohamed A; Geerts AF; Derijks HJ; Wensing M; Egberts A; De Smet PA; de Vries F
    Diabetes Care; 2014 Aug; 37(8):2218-24. PubMed ID: 24842984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin-induced lactic acidosis associated with acute renal failure.
    Safadi R; Dranitzki-Elhalel M; Popovtzer M; Ben-Yehuda A
    Am J Nephrol; 1996; 16(6):520-2. PubMed ID: 8955764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do risk factors for lactic acidosis influence dosing of metformin?
    Millican S; Cottrell N; Green B
    J Clin Pharm Ther; 2004 Oct; 29(5):449-54. PubMed ID: 15482389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of continuation of metformin prior to elective coronary angiography on acute contrast nephropathy in patients with normal or mildly impaired renal functions.
    Oktay V; Calpar Çıralı İ; Sinan ÜY; Yıldız A; Ersanlı MK
    Anatol J Cardiol; 2017 Nov; 18(5):334-339. PubMed ID: 29111980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment with metformin in type 2 diabetes mellitus - new routines when renal function is reduced and in connection with administration of iodine contrast media].
    Sterner G; Frid A
    Lakartidningen; 2018 Apr; 115():. PubMed ID: 29634072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Accumulation of Metformin-associated Lactic Acidosis].
    Rüegg T; Caduff B
    Dtsch Med Wochenschr; 2017 Mar; 142(6):428-431. PubMed ID: 28329904
    [No Abstract]   [Full Text] [Related]  

  • 17. Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements.
    van Berlo-van de Laar IR; Vermeij CG; Doorenbos CJ
    J Clin Pharm Ther; 2011 Jun; 36(3):376-82. PubMed ID: 21545617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin-associated lactic acidosis treated with continuous renal replacement therapy.
    Alivanis P; Giannikouris I; Paliuras C; Arvanitis A; Volanaki M; Zervos A
    Clin Ther; 2006 Mar; 28(3):396-400. PubMed ID: 16750454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactic acidosis induced by metformin in a chronic hemodialysis patient with diabetes mellitus type 2.
    Altun E; Kaya B; Paydaş S; Sarıakçalı B; Karayaylalı I
    Hemodial Int; 2014 Apr; 18(2):529-31. PubMed ID: 24299454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic kidney diseases, metformin and lactic acidosis].
    Borbély Z
    Vnitr Lek; 2016 Apr; 62(4):299-303. PubMed ID: 27250607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.